London and Boston – September 9, 2024 – Cooley advised GeBBS Healthcare Solutions, a global provider of healthcare outsourcing solutions, and ChrysCapital, a top India-focused private equity firm, on the agreement for BPEA Private Equity Fund VIII (EQT Private Capital Asia) to acquire a controlling beneficial interest in GeBBS from ChrysCapital. ChrysCapital acquired a majority stake in GeBBS in December 2018.
Lawyers Ben Shribman, Alfred Browne, Russell Anderson and Rishab Kumar led the Cooley cross-border team advising ChrysCapital, with support from Elizabeth Morrison, Stephanie McFarland, Neelam Atwal, Natasha Kaye, Jack Jones and Ryan Montgomery.
Cooley previously advised ChrysCapital on the close of its oversubscribed $700 million continuation fund in April 2024 and its acquisition of a 75% stake in ProHance Analytics in December 2023.
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 1,300+ lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.